Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference Standard

The identification of the buserelin acetate sample was carried out without using the pharmacopeia reference standard. The identification was based on the spectral NMR data (1H,13C,1H-1H gCOSY,1H-13C gHSQC,1H-13C gHMBC) complex analysis. NMR experiment parameters were determined for the obtaining of...

Full description

Saved in:
Bibliographic Details
Main Authors: N. E. Kuzmina, S. V. Moiseev, V. I. Krylov, V. A. Yashkir, V. A. Merkulov
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/51
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849692730261766144
author N. E. Kuzmina
S. V. Moiseev
V. I. Krylov
V. A. Yashkir
V. A. Merkulov
author_facet N. E. Kuzmina
S. V. Moiseev
V. I. Krylov
V. A. Yashkir
V. A. Merkulov
author_sort N. E. Kuzmina
collection DOAJ
description The identification of the buserelin acetate sample was carried out without using the pharmacopeia reference standard. The identification was based on the spectral NMR data (1H,13C,1H-1H gCOSY,1H-13C gHSQC,1H-13C gHMBC) complex analysis. NMR experiment parameters were determined for the obtaining of spectra with S/N ratio above 50: 1 (1H) and 10:1 (13C). The inexpediency of using the acetate anion signal for calibration of the scale of chemical shifts in the spectra of an aqueous solution of buserelin acetate is shown. The assumption about the effect of the speed of prototropic tautomerism on the disappearance of signals of carbon atoms in positions 4 and 5 of the imidazole ring in the L-histidine fragment of buserelin acetate was made.
format Article
id doaj-art-76b03e4f8371448bbe2b2d5ef8209e4f
institution DOAJ
issn 0235-2990
language Russian
publishDate 2020-05-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-76b03e4f8371448bbe2b2d5ef8209e4f2025-08-20T03:20:37ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-01629-10404650Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference StandardN. E. Kuzmina0S. V. Moiseev1V. I. Krylov2V. A. Yashkir3V. A. Merkulov4Scientific centre for expert evaluation of medical products of the Ministry of Health of Russian FederationScientific centre for expert evaluation of medical products of the Ministry of Health of Russian FederationScientific centre for expert evaluation of medical products of the Ministry of Health of Russian FederationScientific centre for expert evaluation of medical products of the Ministry of Health of Russian FederationScientific centre for expert evaluation of medical products of the Ministry of Health of Russian FederationThe identification of the buserelin acetate sample was carried out without using the pharmacopeia reference standard. The identification was based on the spectral NMR data (1H,13C,1H-1H gCOSY,1H-13C gHSQC,1H-13C gHMBC) complex analysis. NMR experiment parameters were determined for the obtaining of spectra with S/N ratio above 50: 1 (1H) and 10:1 (13C). The inexpediency of using the acetate anion signal for calibration of the scale of chemical shifts in the spectra of an aqueous solution of buserelin acetate is shown. The assumption about the effect of the speed of prototropic tautomerism on the disappearance of signals of carbon atoms in positions 4 and 5 of the imidazole ring in the L-histidine fragment of buserelin acetate was made.https://www.antibiotics-chemotherapy.ru/jour/article/view/51buserelin acetateidentificationnmr spectroscopyreference standard
spellingShingle N. E. Kuzmina
S. V. Moiseev
V. I. Krylov
V. A. Yashkir
V. A. Merkulov
Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference Standard
Антибиотики и Химиотерапия
buserelin acetate
identification
nmr spectroscopy
reference standard
title Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference Standard
title_full Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference Standard
title_fullStr Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference Standard
title_full_unstemmed Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference Standard
title_short Development of a Procedure for the Identification of Pharmaceutical Substance «Buserelin Acetate» by NMR Spectroscopy without Using Pharmacopoeia Reference Standard
title_sort development of a procedure for the identification of pharmaceutical substance buserelin acetate by nmr spectroscopy without using pharmacopoeia reference standard
topic buserelin acetate
identification
nmr spectroscopy
reference standard
url https://www.antibiotics-chemotherapy.ru/jour/article/view/51
work_keys_str_mv AT nekuzmina developmentofaprocedurefortheidentificationofpharmaceuticalsubstancebuserelinacetatebynmrspectroscopywithoutusingpharmacopoeiareferencestandard
AT svmoiseev developmentofaprocedurefortheidentificationofpharmaceuticalsubstancebuserelinacetatebynmrspectroscopywithoutusingpharmacopoeiareferencestandard
AT vikrylov developmentofaprocedurefortheidentificationofpharmaceuticalsubstancebuserelinacetatebynmrspectroscopywithoutusingpharmacopoeiareferencestandard
AT vayashkir developmentofaprocedurefortheidentificationofpharmaceuticalsubstancebuserelinacetatebynmrspectroscopywithoutusingpharmacopoeiareferencestandard
AT vamerkulov developmentofaprocedurefortheidentificationofpharmaceuticalsubstancebuserelinacetatebynmrspectroscopywithoutusingpharmacopoeiareferencestandard